Allarity Therapeutics ALLR
NASDAQ ALLR
$0.88 +0.00 (+0.32%)
At close: Oct 20, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) EBT Margin (2020 - 2026)

Updated

Allarity Therapeutics (ALLR) posted EBT Margin of -11016.00% for Q1 2026.

Analysis

Allarity Therapeutics (ALLR) EBT Margin (2020 - 2026) Analysis & Trends

For FY2025, Allarity Therapeutics' EBT Margin came in at -3509.69%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 26.66%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 25.18%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 18.19%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -131.41%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -4.34%
10 Allarity Therapeutics 13.89 Mn -54.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,016.00%
Sep 30, 2021 -4,700.00%
Sep 30, 2020 -655.20%
API Access

Allarity Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY